Rogue Funds reported an 8.59% return in Q4 2024, with increased volatility. They highlighted Achieve Life Sciences, Inc. (NASDAQ:ACHV) as a promising investment due to positive trial results and potential FDA approval.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay